Clinical characteristics and glucose‐lowering drug utilization among patients initiating liraglutide in Denmark: a routine clinical care prescription study-Reference-Cited by-同舟云学术

Clinical characteristics and glucose‐lowering drug utilization among patients initiating liraglutide in Denmark: a routine clinical care prescription study

Published:2019-04-25 Issue:8 Volume:11 Page:690-694
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:Journal of Diabetes

Author:

Knudsen Jakob S.¹^ORCID,Thomsen Reimar W.¹,Pottegård Anton²,Knop Filip K.³⁴⁵,Sørensen Henrik T.¹

Affiliation:

1. Department of Clinical EpidemiologyAarhus University Hospital Aarhus Denmark

2. Department of Clinical Pharmacology and Pharmacy, Clinical Pharmacology and PharmacyUniversity of Southern Denmark Odense Denmark

3. Deparment of Clinical Metabolic Physiology, Clinical Metabolic Physiology, Steno Diabetes Center CopenhagenGentofte Hospital Hellerup Denmark

4. Department of Clinical Medicine, Faculty of Health and Medical SciencesUniversity of Copenhagen Copenhagen Denmark

5. Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical SciencesUniversity of Copenhagen Copenhagen Denmark

Funder

Clinical Epidemiology Research Foundation, Aarhus University Hospital

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1753-0407.12919

Reference6 articles.

1. Beyond randomized controlled trials: A critical comparison of trials with nonrandomized studies

2. Use of exenatide and liraglutide in Denmark: a drug utilization study

3. Data resource profile: the Danish national prescription registry;Pottegård A;Int J Epidemiol,2017

4. Comparison of the Five Danish Regions Regarding Demographic Characteristics, Healthcare Utilization, and Medication Use—A Descriptive Cross-Sectional Study

5. Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study;The Lancet Regional Health - Europe;2022-03

2. Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997–2017: Time trends in incidence and HbA 1c and glucose‐lowering drug use before and after hypoglycaemia;Endocrinology, Diabetes & Metabolism;2021-01-21

3. Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin Levels;JAMA Network Open;2020-02-07